Medicenna Therapeutics Corp. (MDNAG)
OTOTC · Common · CUSIP 58490H107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for MDNAG and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
58490H107
Market Cap
Micro Cap
Previous Symbol
MDNA (changed 11/20/2023)
Business: Medicenna Therapeutics Corp. is a clinical stage immunotherapy company focused on the development of novel, highly selective versions of IL-2, IL-4 and IL-13 super-agonists, super- antagonists and first in class Empowered Cytokines™ for the treatment of cancer and auto-immune diseases.

Company Contact

CEO
Fahar Merchant
CFO
Elizabeth Williams
Headquarters
2 Bloor St. W., 7th Floor, Toronto, Ontario M4W 3E2, Canada
Phone
416-648-5555
Investor Relations
Elizabeth Williams · 416-648-5555 · ewilliams@medicenna.com
General Email
ir@medicenna.com
SEC EDGAR Filings
View filings »
SEDAR+ Filings
Go to SEDAR+ »